October 2024 Interview for the new grant and project of our group interview in medical Cantabria

                                                             October 2024

Interview for the new grant and project of our group interview in medical cantabria


https://www.medicinacantabria.es/articulo/investigacion/investigadores-predoctorales-uc-estudiaran-cancer-mama-ayudas-aecc/20241004135946001459.html 

Interview for the new grant and project of our group

https://web.unican.es/noticias/Paginas/2024/10/ayudas-predoc-AECC.aspx 





                                                           June 2024

Invitation to give a talk in the Parlamento de Cantabria June 6th 2024.





                                                              May 2024

Sharing nanotecnhology with general public



                                                             November 2023
News papers publishing our discoveries:
Infosalus: 
https://www.infosalus.com/asistencia/noticia-ibbtec-avanza-sistema-transportar-farmaco-experimental-tratamiento-fibrosis-20231129185028.html 
Cantabria economia:
https://www.cantabriaeconomica.com/empresas/el-ibbtec-disena-un-sistema-para-transportar-un-farmaco-experimental-contra-la-fibrosis/



Interview to Ana V Villar PI of FIBROHEART about the last scientific publication of her group:

                    


                 https://web.unican.es/noticias/Paginas/2023/11/nanofarmaco-experimental-fibrosis.aspx 

                    https://youtu.be/zFnNpQ1DJzI?si=jFEILgXhC4K1oPVD 


Fibroblast-derived extracellular vesicles as trackable efficient transporters of an experimental nanodrug with fibrotic heart and lung targeting. Published in Theranostics 2024, Vol. 14, Issue 1


                                                            December 2022
Interview to Ana V Villar PI of FIBROHEART in farmaforum magazine. Follow this link:

https://www.farmabiotec.com/revistas/numero-4-invierno-2022-2022



Ana V Villar director of a symposium accepted at the 45th SEBBM congress (Zaragoza 5-8 September 2023)


                                                        October 2022    

We are part of a european consortium that start with the partnership of 13 universities.

Fibroheart group was selected to belong to this european consortium

https://twitter.com/Nanomed_CSIC/status/1582318677235765250?t=b21vlnilPJHig_1fHeSQiw&s=19


                                                         September 2022

- Invitation to explain our research at the IFEMA Madrid Congress Health & Research forum  FARMA BIOTECH FARMAFORUM next month 

- Our FIBROHEAT group has been selected as a beneficiary of an OpenLab-CEO 2022 OpenLab-CEO grant. Thanks to this grant one of our projects will be oriented to patent some of our potential anti-fibrotic solutions. Congratulations to the group.

-We start an interesting collaboration with CSIC Madrid on organoids. Wellcome Esther.


-Predoctoral position is available for application from now until the end of September 2022. Write to villarav@unican.es with your CV, motivation letter and degree.




August 2022






 -Look at FibroHeart you tube chanel 

https://www.youtube.com/watch?v=W7d-fUEU22E 


-Predoctoral position available

Predoctoral position is available for application from now until September 2022. Write to villarav@unican.es with your CV, motivation letter and degree.

Look at the hiring section of this blog

No hay comentarios:

Publicar un comentario